vimarsana.com

Latest Breaking News On - Ingrid delaet - Page 3 : vimarsana.com

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Bought by M&G Investment Management Ltd.

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Bought by M&G Investment Management Ltd.
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United-states
Neurocrine-biosciences
Ingrid-delaet
Dimensional-fund-advisors
Holdings-channel
Mg-investment-management-ltd
Ieq-capital
Needham-company
Neurocrine-biosciences-inc
Envestnet-portfolio-solutions-inc
G-investment-management-ltd
Jpmorgan-chase-co

M&G Investment Management Ltd. Acquires 5,781 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

M&G Investment Management Ltd. Acquires 5,781 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Los-angeles
California
United-states
Ingrid-delaet
Neurocrine-biosciences
G-investment-management-ltd
Jacobs-levy-equity-management-inc
Mg-investment-management-ltd
Neurocrine-biosciences-inc
Nasdaq
Charles-schwab-investment-management-inc
Citigroup

Brokers Set Expectations for Neurocrine Biosciences, Inc.'s FY2025 Earnings (NASDAQ:NBIX)

Brokers Set Expectations for Neurocrine Biosciences, Inc.'s FY2025 Earnings (NASDAQ:NBIX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
Los-angeles
California
Eric-benevich
Neurocrine-biosciences
Leerink-partnrs
Neurocrine-bioscience
Ingrid-delaet
Wells-fargo-company
Neurocrine-biosciences-company-profile
Barclays
Neurocrine-biosciences-inc

Citigroup Raises Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $150.00

Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its target price increased by Citigroup from $140.00 to $150.00 in a research report released on Friday, Benzinga reports. The firm currently has a neutral rating on the stock. Other analysts also recently issued research reports about the company. Oppenheimer raised their price objective on Neurocrine Biosciences from […]

Los-angeles
California
United-states
Neurocrine-biosciences
Davidw-boyer
Ingrid-delaet
Needham-company
Cantor-fitzgerald
Vanguard-group-inc
Neurocrine-biosciences-inc
Capital-partners
Jpmorgan-chase-co

Neurocrine Biosciences (NASDAQ:NBIX) PT Raised to $216.00 at Oppenheimer

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price objective lifted by research analysts at Oppenheimer from $200.00 to $216.00 in a research report issued on Thursday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Oppenheimer’s target price would suggest a potential upside of 53.51% from the stock’s previous close. […]

New-york
United-states
Neurocrine-biosciences
Ingrid-delaet
Eric-benevich
Neurocrine-biosciences-company-profile
Goldman-sachs-group
Cantor-fitzgerald
Securities-exchange-commission
Fintrust-capital-advisors
Neurocrine-biosciences-inc
Nasdaq

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.